Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Antidepressants Part II

5,596 views

Published on

This PPT is part of 2 of 2 lectures given to second year pharmacy students in a pharmacology & toxicology class.

Published in: Health & Medicine
  • I tried Semenax and noticed results after 3 days! I had tried other products... But Semenax WORKS! ■■■ https://bit.ly/2No6XLF
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here

Antidepressants Part II

  1. 1. Antidepressants IIBrian J. Piper, Ph.D., M.S. January 28, 2013
  2. 2. Goals• Light therapy for Seasonal Affective Disorder• Tricyclics & Tetracyclics• Monoamine Oxidase Inhibitors• Serotonin Norepinephrine Reuptake Inhibitors (SNRI)• Saint John’s wort• STAR*D
  3. 3. Seasonal Affective Disorder • Depressive symptoms in fall-winter • Light-Therapy (10k lux, 30 min/day) – retina -> hypothalamus (2) -> pineal (3) – morning/ evening – rapid therapeutic onset (days) – good safety profile 2 3Pail et al. (2011). Neuropsychobiology, 54, 162-164.
  4. 4. Light-Therapy Meta-Analysis • Effect Size = (mean Experimental – meanControl)/ Standard Deviation) – 0.20: small – 0.50: medium – 0.80: large <- 0.84Golden et al. (1995). American Journal of Psychiatry, 162(4), 656-662.
  5. 5. Tricyclic Antidepressants (TCA)• Developed from antipsychotic drugs (1960s)• MOA: NET/SERT inhibition; anticholinergic• Gold standard for efficacy• Side effects: sedation• Concern with overdose
  6. 6. Affinity (dirty drugs) --------------------------------------------------------------------------- ---------------- ->Eur J Pharmacol. 340 (2–3): 249–258; Psychopharmacology, 114 (4): 559–565.
  7. 7. Tetracyclic Antidepressant (TeCA) • Example: mirtazapine (Remeron) • MOA: α2 & 5-HT2 antagonist • Efficacy: equivalent to TCA • Adverse Effects: weight gain, somnolence • Other: onset faster than SSRIsWatanabe et al. (2011). Cochrane Review, Issue 11, CD006528http://www.howjsay.com/index.php?word=mirtazapine&submit=Submit
  8. 8. Serotonin & Norepinephrine Reuptake Inhibitors• Example: venlafaxine (Efexor)• MOA: SERT/NET• Efficacy: good ( > SSRIs)• Adverse Effects: nausea, somnolence, sexual• Half-life: 5 hours
  9. 9. SSRI Discontinuation Syndrome • Occurs for ≈2 weeks following withdrawal of antidepressants that block SERT • Symptoms – Flu-like: nausea, dizziness, diarrhea – “brain zaps” – emotional volatility • Solution: prolonged taperingExample Patient (0:52 – 1:13, 4:45 – 6:30): http://www.youtube.com/watch?v=x0HUtRCEMykLong but sensitive (10 min): http://www.youtube.com/watch?v=2Bt2ftSgDDQNielson et al. (2011). Addiction, 107, 900-908.
  10. 10. Monoamine Oxidase • MAOA : 5-HT, NE, DA, tyramine • MAOB : phenyltheylamine, DA, tyramine • Inhibition: – Old (1950s): irreversible/non-selective – New (1990s): reversible/selective (MAOA)Stahl, S. (1998). Essential Psychopharmacology, p. 580.
  11. 11. Monoamine Oxidase Inhibitors• History: tuberculosis (serendipity)• Example: phenelzine (Nardil)• MOA: blocks breakdown of NE, 5-HT > DA• Efficacy: excellent• Adverse Effects: postural hypotension
  12. 12. MAO-I & “cheese” effect • Old view: avoid cheeses, alcohol, etc. • New View: avoid aged cheese, spoiled meats, – Typical American diet does not contain clinically meaningful levels of tyramine (10 mg)Stahl, S. (2008). Essential Psychopharmacology, p. 587-589.
  13. 13. MAO-I & “cheese” effect • New View: avoid aged cheese (Cheshire, Danish bleu)McCabe-Sellers et al. (2006). J of Food Composition & Analysis, 19, S58-S65.
  14. 14. Serotonin Syndrome • Cluster of autonomic, motor & mental status changes resulting from excess 5-HT (5-HT2A) Agents MAO-Is TCA SSRIs opiate analgesics cough medicines (OTC) antibiotics triptans anti-nausea herbal products abused drugsBoyer & Shannon (2005). New England Journal of Medicine, 352, 1112-1120.
  15. 15. Case of Libby Zion• ER visit for fever, agitation, shaking movements 1965 - 1984• Interns administered meperidine, later restraints• Hyperthermia & cardiac arrest• Intern hours/week = 70
  16. 16. Bupropion • MOA: ?, NET & DAT inhibitor • Adverse Effects: dry mouth, high dose seizures • Efficacy: – monotherapy ≈ SRI – augmentation: better than monotherapy • Other: APA recommends as a first-line therapy for moderate depressionMoreira, R. (2011). Clinical Drug Investigation, 31(S1), 5-17.
  17. 17. Prior Sequenced Treatments Antidepressant Alternatives to Relieve Depression (STAR*D) TrialsMulti-site Yes YesBlinded Yes- Randomized No-Open Controlled TrialComorbid excluded includedConditionPatientsDuration 6-12 weeks years
  18. 18. STAR*D Design & Results 25.5% 26.6% 25.5% 39.0% 32.9% 29.4% 41.9%Remission: Level 1: 32.9%; Level 2: 30.6%, Level 3: 13.6% Level 2: Switch = 27.0%; Augment = 35%
  19. 19. Questions• If you had a family member with MDD, based on the STAR*D results, consider: – How good (efficacious) is the gold standard? – Is there an advantage of augmentation versus switching? – Were any other findings unexpected?
  20. 20. MDD: Endocrine Component?Stahl (2008). Essential Psychopharmacology, p. 616-616.
  21. 21. SRIs & Pregnancy• Pregnancy is a high-risk period for depression• SRIs may carry slight risks for the fetus – persistent pulmonary hypertension – low birth weight• Untreated MDD does cause fetal risk
  22. 22. Summary • Best ----------------------------------WorstTolerability SRI > SNRI > TCA > MAO-IEfficacy TCA > MAO-I > SNRI > SRI
  23. 23. -----------Stahl (2008). Essential Psychopharmaology, p. 519. -----------------
  24. 24. Saint John’s wort (Hypericum perforatum)• MOA: ?, SERT• Adverse Effects: photosensitivity• Concern: quality control• Efficacy: mild to moderate depression
  25. 25. MDD Trial ----------------------------------------------------------------------------- Quit 27%-29%Davidson et al. (2002). Journal of the American Medical Association, 287, 1807-1814.
  26. 26. Saint John’s wort • MOA: ?, SERT • Adverse Effects: photosensitivity • Other: ↑CYP3A4 • Efficacy: “The available evidence suggests that the hypericum extracts tested in the included trials: a) are superior to placebo in patients with major depression; b) are similarly effective as standard antidepressants; c) and have fewer side effects than standard antidepressants.”Linde et al. (2009). Cochrane Reviews, DOI: 10.1002/14651858.CD000448.pub3
  27. 27. Self-Test• The only antidepressant whose mechanism of action includes inhibiting NET & DAT is: – A) hypericum perforatum – B) fluvoxamine – C) mirtazapine – D) bupropion – E) clomipramine

×